Cancer of Unknown Primary, NOS — knowledge graph · CancerIndex

Knowledge graph · Cancer

Cancer of Unknown Primary, NOS

subtype

Identifier: CI-CAN-00009374
Entity page: /cancer/cancer-of-unknown-primary-nos ↗
Edges: 12

Neighbours: 4 drugs8 trials
Drawn: 12 of 12 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Cancer of Unknown Primary, NOS investigated in trials for …INVESTIGATED_IN_TRIALSderived4 of 4
→ investigated in trials for	Carboplatinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Cancer of Unknown Primary, NOS	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Cisplatinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants

Cancer of Unknown Primary, NOS studied in …STUDIED_INderived8 of 8
→ studied in	NCT06638931Phase 2 · recruiting Agnostic Therapy in Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 8 trials mapped (5 active)	—	—	Cancer of Unknown Primary, NOS	1	Observed	clinicaltrials	graph →
→ studied in	NCT06695494recruiting Enabling Genomic Testing in Cancer of Unknown Primary · condition mapped ONTOLOGY_EXACT · 8 trials mapped (5 active)	—	—	Cancer of Unknown Primary, NOS	1	Observed	clinicaltrials	graph →
→ studied in	NCT07434180Phase 2 · not yet recruiting Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary · condition mapped ONTOLOGY_EXACT · 8 trials mapped (5 active)	—	—	Cancer of Unknown Primary, NOS	1	Observed	clinicaltrials	graph →
→ studied in	NCT06869174Phase 2 · not yet recruiting Pucotenlimab Combined with MRG002 for HER2-positive Cancer of Unknown Primary · condition mapped ONTOLOGY_EXACT · 8 trials mapped (5 active)	—	—	Cancer of Unknown Primary, NOS	1	Observed	clinicaltrials	graph →
→ studied in	NCT06644716NA · recruiting [18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary Origin · condition mapped ONTOLOGY_EXACT · 8 trials mapped (5 active)	—	—	Cancer of Unknown Primary, NOS	1	Observed	clinicaltrials	graph →
→ studied in	NCT02897375Phase 1 · completed Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 8 trials mapped (5 active)	—	—	Cancer of Unknown Primary, NOS	1	Observed	clinicaltrials	graph →
→ studied in	NCT04848597Phase 2 · unknown PD-1 Inhibitor and Nab-paclitaxel and Bevacizumab in CUP · condition mapped ONTOLOGY_EXACT · 8 trials mapped (5 active)	—	—	Cancer of Unknown Primary, NOS	1	Observed	clinicaltrials	graph →
→ studied in	NCT05241132Phase 2 · unknown Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary · condition mapped ONTOLOGY_EXACT · 8 trials mapped (5 active)	—	—	Cancer of Unknown Primary, NOS	1	Observed	clinicaltrials	graph →